According to USPSTF recommendations, which adults should receive aspirin therapy for primary prevention of cardiovascular disease?
-
A
All adults over age 40 regardless of cardiovascular risk
-
B
Adults aged 40 to 59 with 10% or greater 10-year CVD risk where benefit-harm balance is individualized; aspirin is NOT recommended for primary prevention in adults 60 and older
-
C
All adults with hypertension regardless of age
-
D
Adults under age 30 at high CVD risk